5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

A number of pharmacogenetic studies have been carried out in non-small-cell lung cancer (NSCLC) to identify and characterize genes involved in chemotherapy activity. However, the results obtained so far are controversial and no reliable biomarker is currently used to predict clinical benefit from pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Toffalorio, Francesca, Santarpia, Mariacarmela, Radice, Davide, Jaramillo, Christopher Adrian, Spitaleri, Gianluca, Manzotti, Michela, Catania, Chiara, Jordheim, Lars Petter, Pelosi, Giuseppe, Peters, Godefridus J., Tibaldi, Carmelo, Funel, Niccola, Spaggiari, Lorenzo, de Braud, Filippo, De Pas, Tommaso, Giovannetti, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893252/
https://www.ncbi.nlm.nih.gov/pubmed/29662657
http://dx.doi.org/10.18632/oncotarget.24505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893252/
https://www.ncbi.nlm.nih.gov/pubmed/29662657
http://dx.doi.org/10.18632/oncotarget.24505

Ejemplares similares